BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35070473)

  • 1. Optimising the oil phases of aluminium hydrogel-stabilised emulsions for stable, safe and efficient vaccine adjuvant.
    Yuan L; Gao XD; Xia Y
    Front Chem Sci Eng; 2022; 16(6):973-984. PubMed ID: 35070473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Squalene-Based Oil-in-Water Emulsion Adjuvants Using a Self-Emulsifying Drug Delivery System for Enhanced Antigen-Specific Antibody Titers.
    Chae GE; Kim DW; Jin HE
    Int J Nanomedicine; 2022; 17():6221-6231. PubMed ID: 36531114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving the Stability and Effectiveness of Immunotropic Squalene Nanoemulsion by Adding Turpentine Oil.
    Krasnova OA; Minaychev VV; Akatov VS; Fadeev RS; Senotov AS; Kobyakova MI; Lomovskaya YV; Lomovskiy AI; Zvyagina AI; Krasnov KS; Shatalin YV; Penkov NV; Zhalimov VK; Molchanov MV; Palikova YA; Murashev AN; Maevsky EI; Fadeeva IS
    Biomolecules; 2023 Jun; 13(7):. PubMed ID: 37509089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel oil-in-water emulsion as a potential adjuvant for influenza vaccine: development, characterization, stability and in vivo evaluation.
    Deng J; Cai W; Jin F
    Int J Pharm; 2014 Jul; 468(1-2):187-95. PubMed ID: 24704309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvanted pandemic influenza vaccine: variation of emulsion components affects stability, antigen structure, and vaccine efficacy.
    Fox CB; Barnes V L; Evers T; Chesko JD; Vedvick TS; Coler RN; Reed SG; Baldwin SL
    Influenza Other Respir Viruses; 2013 Sep; 7(5):815-26. PubMed ID: 23122325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Particulate Alum via Pickering Emulsion for an Enhanced COVID-19 Vaccine Adjuvant.
    Peng S; Cao F; Xia Y; Gao XD; Dai L; Yan J; Ma G
    Adv Mater; 2020 Oct; 32(40):e2004210. PubMed ID: 32864794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of Squalene Oil-Based Emulsion Adjuvants Employing a Self-Emulsifying Drug Delivery System and Assessment of
    Bastola R; Seo JE; Keum T; Noh G; Choi JW; Shin JI; Kim JH; Lee S
    Pharmaceutics; 2019 Dec; 11(12):. PubMed ID: 31835466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of formulation and particle size on stability and immunogenicity of oil-in-water emulsion adjuvants.
    Iyer V; Cayatte C; Guzman B; Schneider-Ohrum K; Matuszak R; Snell A; Rajani GM; McCarthy MP; Muralidhara B
    Hum Vaccin Immunother; 2015; 11(7):1853-64. PubMed ID: 26090563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory and physical effects of oil composition in vaccine adjuvant emulsions.
    Fox CB; Baldwin SL; Duthie MS; Reed SG; Vedvick TS
    Vaccine; 2011 Nov; 29(51):9563-72. PubMed ID: 21906648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oil components modulate physical characteristics and function of the natural oil emulsions as drug or gene delivery system.
    Chung H; Kim TW; Kwon M; Kwon IC; Jeong SY
    J Control Release; 2001 Apr; 71(3):339-50. PubMed ID: 11295226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AF03, an alternative squalene emulsion-based vaccine adjuvant prepared by a phase inversion temperature method.
    Klucker MF; Dalençon F; Probeck P; Haensler J
    J Pharm Sci; 2012 Dec; 101(12):4490-500. PubMed ID: 22941944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manufacture of Oil-in-Water Emulsion Adjuvants.
    Haensler J
    Methods Mol Biol; 2017; 1494():165-180. PubMed ID: 27718193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of Freeze-Drying Oil-in-Water Emulsion Adjuvants and Subunit Proteins to Enable Single-Vial Vaccine Drug Products.
    Iyer V; Cayatte C; Marshall JD; Sun J; Schneider-Ohrum K; Maynard SK; Rajani GM; Bennett AS; Remmele RL; Bishop SM; McCarthy MP; Muralidhara BK
    J Pharm Sci; 2017 Jun; 106(6):1490-1498. PubMed ID: 28259764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. O/W Nanoemulsion as an Adjuvant for an Inactivated H3N2 Influenza Vaccine: Based on Particle Properties and Mode of Carrying.
    Zhao L; Zhu Z; Ma L; Li Y
    Int J Nanomedicine; 2020; 15():2071-2083. PubMed ID: 32273703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclodextrin stabilised emulsions and cyclodextrinosomes.
    Mathapa BG; Paunov VN
    Phys Chem Chem Phys; 2013 Nov; 15(41):17903-14. PubMed ID: 24043288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Starch-lauric acid complex-stabilised Pickering emulsion gels enhance the thermo-oxidative resistance of flaxseed oil.
    Feng Y; Zhang B; Fu X; Huang Q
    Carbohydr Polym; 2022 Sep; 292():119715. PubMed ID: 35725189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unsaturated Squalene Content in Emulsion Vaccine Adjuvants Plays a Crucial Role in ROS-Mediated Antigen Uptake and Cellular Immunity.
    Huang CH; Huang CY; Huang MH
    Mol Pharm; 2018 Feb; 15(2):420-429. PubMed ID: 29237267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomodulatory and physical effects of phospholipid composition in vaccine adjuvant emulsions.
    Fox CB; Baldwin SL; Duthie MS; Reed SG; Vedvick TS
    AAPS PharmSciTech; 2012 Jun; 13(2):498-506. PubMed ID: 22415641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of serum on the stability and the transfection activity of the cationic lipid emulsion with various oils.
    Kim YJ; Kim TW; Chung H; Kwon IC; Sung HC; Jeong SY
    Int J Pharm; 2003 Feb; 252(1-2):241-52. PubMed ID: 12550800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a novel oil-in-water emulsion and evaluation of its potential adjuvant function in a swine influenza vaccine in mice.
    Zhang J; Miao J; Han X; Lu Y; Deng B; Lv F; Zhao Y; Ding C; Hou J
    BMC Vet Res; 2018 Dec; 14(1):415. PubMed ID: 30577861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.